Bortezomib-based vs non-bortezomib-based post-transplantation treatment in multiple myeloma patients: a systematic review and meta-analysis of Phase III …

X Liu, CK He, X Meng, L He, K Li, Q Liang… - OncoTargets and …, 2015 - Taylor & Francis
Objective To evaluate the efficacy and safety of bortezomib-based vs non-bortezomib-based
post-transplantation therapy in patients with multiple myeloma. Methods Data of relevant …
被引用次数：16 相关文章

Bortezomib-based vs non-bortezomib-based post-transplantation treatment in multiple myeloma patients: a systematic review and meta-analysis of Phase III …

X Liu, CK He, X Meng, L He, K Li… - OncoTargets & …, 2015 - search.ebscohost.com
Objective: To evaluate the efficacy and safety of bortezomib-based vs non-bortezomib-
based post-transplantation therapy in patients with multiple myeloma. Methods: Data of …

Bortezomib-based vs non-bortezomib-based post-transplantation treatment in multiple myeloma patients: a systematic review and meta-analysis of Phase III …

X Liu, CK He, X Meng, L He, K Li… - OncoTargets and …, 2015 - pubmed.ncbi.nlm.nih.gov
Objective To evaluate the efficacy and safety of bortezomib-based vs non-bortezomib-based
post-transplantation therapy in patients with multiple myeloma. Methods Data of relevant …

Bortezomib-based vs non-bortezomib-based post-transplantation treatment in multiple myeloma patients: a systematic review and meta-analysis of Phase III …

X Liu, CK He, X Meng, L He, K Li, Q Liang… - OncoTargets and …, 2015 - go.gale.com
Objective: To evaluate the efficacy and safety of bortezomib-based vs non-bortezomib-
based post-transplantation therapy in patients with multiple myeloma. Methods: Data of …
[PDF] academia.edu

[PDF][PDF] Bortezomib-based vs non-bortezomib-based post-transplantation treatment in multiple myeloma patients: a systematic review and meta-analysis of Phase iii …

X Meng - OncoTargets and Therapy, 2015 - academia.edu
Objective: To evaluate the efficacy and safety of bortezomib-based vs non-bortezomib-
based post-transplantation therapy in patients with multiple myeloma. Methods: Data of …
[HTML] nih.gov

[HTML][HTML] Bortezomib-based vs non-bortezomib-based post-transplantation treatment in multiple myeloma patients: a systematic review and meta-analysis of Phase III …

X Liu, CK He, X Meng, L He, K Li, Q Liang… - OncoTargets and …, 2015 - ncbi.nlm.nih.gov
Objective To evaluate the efficacy and safety of bortezomib-based vs non-bortezomib-based
post-transplantation therapy in patients with multiple myeloma. Methods Data of relevant …
[PDF] researchgate.net

[PDF][PDF] Bortezomib-based vs non-bortezomib-based post-transplantation treatment in multiple myeloma patients: a systematic review and meta-analysis of Phase iii …

X Meng - OncoTargets and Therapy, 2015 - researchgate.net
Objective: To evaluate the efficacy and safety of bortezomib-based vs non-bortezomib-
based post-transplantation therapy in patients with multiple myeloma. Methods: Data of …
[PDF] semanticscholar.org

[PDF][PDF] Bortezomib-based vs non-bortezomib-based post-transplantation treatment in multiple myeloma patients: a systematic review and meta-analysis of Phase iii …

X Meng - OncoTargets and Therapy, 2015 - pdfs.semanticscholar.org
Objective: To evaluate the efficacy and safety of bortezomib-based vs non-bortezomib-
based post-transplantation therapy in patients with multiple myeloma. Methods: Data of …

Bortezomib-based vs non-bortezomib-based post-transplantation treatment in multiple myeloma patients: a systematic review and meta-analysis of Phase III …

X Liu, CK He, X Meng, L He, K Li, Q Liang… - OncoTargets and …, 2015 - dovepress.com
Objective: To evaluate the efficacy and safety of bortezomib-based vs non-bortezomib-
based post-transplantation therapy in patients with multiple myeloma. Methods: Data of …

Bortezomib-based vs non-bortezomib-based post-transplantation treatment in multiple myeloma patients: a systematic review and meta-analysis of Phase III …

X Liu, CK He, X Meng, L He, K Li, Q Liang… - Oncotargets and …, 2015 - europepmc.org
Objective To evaluate the efficacy and safety of bortezomib-based vs non-bortezomib-based
post-transplantation therapy in patients with multiple myeloma. Methods Data of relevant …